224 related articles for article (PubMed ID: 16332144)
1. Initial and long-term management of autoimmune neuropathies.
Koski CL
CNS Drugs; 2005; 19(12):1033-48. PubMed ID: 16332144
[TBL] [Abstract][Full Text] [Related]
2. IVIg in idiopathic autoimmune neuropathies: analysis in the light of the latest results.
Nobile-Orazio E; Terenghi F
J Neurol; 2005 May; 252 Suppl 1():I7-13. PubMed ID: 15959669
[TBL] [Abstract][Full Text] [Related]
3. [Autoimmune neuropathies: diagnosis, treatment, and recent topics].
Ueda M; Kusunoki S
Brain Nerve; 2011 Jun; 63(6):549-55. PubMed ID: 21613658
[TBL] [Abstract][Full Text] [Related]
4. Treatment of immune-mediated, dysimmune neuropathies.
Finsterer J
Acta Neurol Scand; 2005 Aug; 112(2):115-25. PubMed ID: 16008538
[TBL] [Abstract][Full Text] [Related]
5. Immune mediated neuropathies--an update on therapeutic strategies.
Czaplinski A; Steck AJ
J Neurol; 2004 Feb; 251(2):127-37. PubMed ID: 14991345
[TBL] [Abstract][Full Text] [Related]
6. Treatment of inflammatory and paraproteinemic neuropathies.
Monaco S; Turri E; Zanusso G; Maistrello B
Curr Drug Targets Immune Endocr Metabol Disord; 2004 Jun; 4(2):141-8. PubMed ID: 15180454
[TBL] [Abstract][Full Text] [Related]
7. [Immunoglobulin therapy of chronic inflammatory neuropathies].
Grehl H; Jaspert A; Claus D; Neundörfer B
Nervenarzt; 1996 Dec; 67(12):1003-10. PubMed ID: 9082188
[TBL] [Abstract][Full Text] [Related]
8. Treatment of immune neuropathies.
Van Doorn PA; Garssen MP
Curr Opin Neurol; 2002 Oct; 15(5):623-31. PubMed ID: 12352007
[TBL] [Abstract][Full Text] [Related]
9. The role of IVIg in autoimmune neuropathies: the latest evidence.
Hughes R
J Neurol; 2008 Jul; 255 Suppl 3():7-11. PubMed ID: 18685920
[TBL] [Abstract][Full Text] [Related]
10. [Diagnosis and management of immune-mediated neuropathies].
Hsieh ST
Acta Neurol Taiwan; 2004 Mar; 13(1):39-45. PubMed ID: 15315301
[TBL] [Abstract][Full Text] [Related]
11. Complications of Immunoglobulin Therapy and Implications for Treatment of Inflammatory Neuropathy: A Review.
Abbas A; Rajabally YA
Curr Drug Saf; 2019; 14(1):3-13. PubMed ID: 30332974
[TBL] [Abstract][Full Text] [Related]
12. [Multifocal motor neuropathy: a retrospective study of the response to high-dose intravenous immunoglobulin (IVIg) and current perspectives for diagnosis and treatment].
Léger JM; Viala K; Maisonobe T; Bouche P
Bull Acad Natl Med; 2007 Oct; 191(7):1395-407; discussion 1407-9. PubMed ID: 18447061
[TBL] [Abstract][Full Text] [Related]
13. Comparing treatment options for chronic inflammatory neuropathies and choosing the right treatment plan.
Nobile-Orazio E; Gallia F; Terenghi F; Bianco M
Expert Rev Neurother; 2017 Aug; 17(8):755-765. PubMed ID: 28597710
[TBL] [Abstract][Full Text] [Related]
14. Clinical trials in CIDP and chronic autoimmune demyelinating polyneuropathies.
Dalakas MC
J Peripher Nerv Syst; 2012 May; 17 Suppl 2():34-9. PubMed ID: 22548621
[TBL] [Abstract][Full Text] [Related]
15. The use of intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: evidence-based indications and safety profile.
Dalakas MC
Pharmacol Ther; 2004 Jun; 102(3):177-93. PubMed ID: 15246245
[TBL] [Abstract][Full Text] [Related]
16. Treatment of dys-immune neuropathies.
Nobile-Orazio E
J Neurol; 2005 Apr; 252(4):385-95. PubMed ID: 15834625
[TBL] [Abstract][Full Text] [Related]
17. [Intravenous immunoglobulin-induced eczematous eruption in autoimmune neuromuscular diseases].
Hatake S; Shimizu F; Honda M; Takahashi S; Koga M; Kimura K; Kanda T
Rinsho Shinkeigaku; 2022 Apr; 62(4):267-271. PubMed ID: 35354723
[TBL] [Abstract][Full Text] [Related]
18. Treatment of chronic inflammatory demyelinating polyneuropathy.
Comi G; Roveri L
Ital J Neurol Sci; 1998 Oct; 19(5):261-9. PubMed ID: 10933445
[TBL] [Abstract][Full Text] [Related]
19. Subcutaneous versus intravenous immunoglobulin for chronic autoimmune neuropathies: A meta-analysis.
Racosta JM; Sposato LA; Kimpinski K
Muscle Nerve; 2017 Jun; 55(6):802-809. PubMed ID: 27649063
[TBL] [Abstract][Full Text] [Related]
20. Expression of chemokine receptors on peripheral blood mononuclear cells of patients with immune-mediated neuropathies treated with intravenous immunoglobulins.
Trebst C; Brunhorn K; Lindner M; Windhagen A; Stangel M
Eur J Neurol; 2006 Dec; 13(12):1359-63. PubMed ID: 17116220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
